Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression. [electronic resource]
Producer: 20150113Description: 7499-504 p. digitalISSN:- 1423-0380
- Carcinoma, Squamous Cell -- drug therapy
- Cell Proliferation -- drug effects
- Down-Regulation
- E1A-Associated p300 Protein -- antagonists & inhibitors
- Head and Neck Neoplasms -- drug therapy
- Humans
- Hypopharyngeal Neoplasms -- drug therapy
- Midazolam -- pharmacology
- Retinoblastoma Protein -- physiology
- Squamous Cell Carcinoma of Head and Neck
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.